Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
6
Bearish filings
0
Named actors
6
Disclosed $ (bull / bear)
$83K / $0
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-08-27 | Chief Executive Officer Antz Christoph Rudiger | bought | $8K | SEC ↗ |
| 2026-08-27 | Director Baumann Oliver Rolf | bought | $75K | SEC ↗ |
| 2026-06-16 | Activist (13D) European Molecular Biology Laboratory | disclosed an activist stake (13D) | — | SEC ↗ |
| 2026-06-16 | Activist (13D) Deck David Lukas | disclosed an activist stake (13D) | — | SEC ↗ |
| 2026-06-15 | Activist (13D) Xlife Sciences AG | disclosed an activist stake (13D) | — | SEC ↗ |
| 2026-06-15 | Activist (13D) Schoeni Gilbert Edgar | disclosed an activist stake (13D) | — | SEC ↗ |
Want the read, not just the record?
Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.
Create a free account →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals